Company Legal Name
Latest Valuation
Founded Year
Headquarter
Neuspera Medical develops implantable neuromodulation devices designed to treat urinary urge incontinence through advanced wireless charging technology. Based in San Jose, the company addresses a significant medical need affecting millions of patients worldwide who suffer from overactive bladder conditions. Neuspera's innovative approach combines targeted neural stimulation with convenient wireless power delivery, potentially offering patients a more user-friendly alternative to existing treatment options. The company's technology represents a notable advancement in the urological device market, where traditional solutions often require invasive battery replacement procedures. Neuspera continues to focus on advancing its neuromodulation platform for broader therapeutic applications.
Available in most regions; subject to local regulations.
Open to non-accredited investors with KYC/AML compliance. U.S. investors must meet SEC requirements.
$10 per token, enabling fractionalized access to Pre-IPO shares.
Mandatory identity (KYC) and proof of funds checks.
Variable, applied to investment amounts.
Charged on realized profits.
Tokens may be locked for 6–12 months; resale depends on secondary market liquidity.
Prices reflect past funding rounds, not guaranteed future value.
Biotech depends on regulatory approvals; fintech faces evolving digital asset rules.
Blockchain or custodian issues could delay transfers or verification.
Changing laws may affect tradability or taxation.
How can I buy Neuspera Medical pre-IPO shares through Jarsy?
You can create an account, complete KYC verification, and start investing from just $10. Shares are fractionalized, so you can access pre-IPO opportunities without high entry barriers.
What is the current stock price and valuation of Neuspera Medical ?
The latest valuation of Neuspera Medical is , The live stock price chart shows historical price movements and company valuation trends. Investors can track performance before the IPO.
What is the minimum investment amount required to invest in Neuspera Medical ?
The minimum investment is $10, enabling fractionalized access to Neuspera Medical pre-IPO shares.
What fees will I pay when investing in Neuspera Medical pre-IPO shares?
Fees include platform fees and carried interest on realized profits.
What risks are involved in Neuspera Medical pre-IPO stock investments?
Risks include liquidity lock-ups, valuation uncertainty, industry-specific risks, regulatory changes, and potential custody or tokenization issues.
How does Jarsy ensure transparency of reserves and assets?
Each Jarsy issued Token is backed 1:1 by the economic rights of a corresponding share held by Jarsy’s Delaware LLC ( an LLC created for custody purposes). When a liquidation event happens, Jarsy would liquidate the shares and return the equivalent dollar value to token holders based on their economic interest. This structure ensures full transparency and direct backing of every token. All the supply and transactions information of the token can be verified independently through blockchain.
Can I sell my Neuspera Medical pre-IPO shares backed token before the IPO?
You may redeem your tokens through the Jarsy platform; however, settlement is not guaranteed and is subject to available liquidity and market demand.